Telethon Funding in Trentino
Giovanni Piccoli Awarded a Grant for Parkinson’s Disease Research
The Telethon Foundation has awarded funding under the 2025–2027 multi-round call to a research project coordinated by Professor Giovanni Piccoli, focused on developing new therapeutic strategies for Parkinson’s disease.
The project, entitled “GLP-1 Receptor Agonists as a Therapeutic Opportunity in Parkinson’s Disease,” was selected in the first round of the second edition of the call, which funded 27 research projects nationwide for a total of €7 million. In the Trentino–Alto Adige region, two research groups received funding totaling €200,000.
The Telethon Foundation’s “multi-round” call supports basic and preclinical research projects on rare genetic diseases, submitted by non-profit public and private research institutions. The selection process is highly rigorous and comprises two stages, culminating in the evaluation of full proposals by an international medical-scientific committee composed of 26 high-level experts.
The project, coordinated by Professor Giovanni Piccoli, fits within this context of scientific excellence and aims to explore the therapeutic potential of GLP-1 receptor agonists for the treatment of Parkinson’s disease, contributing to the development of new strategies to address a complex neurological condition that still lacks definitive therapies.
The Telethon funding represents an important recognition of the quality of the research conducted within our Department and further strengthens the University’s commitment to the study of neurological and neurodegenerative diseases.
